Metropolitan Kentjana Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Metropolitan Kentjana Tbk. trades at Rp21,400 (market cap 20.39T, 40.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Metropolitan Kentjana Tbk. is far larger — about 121.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 40.5K). Which is the better fit depends on your goals.
| MKPI | OBAT | |
|---|---|---|
Market Cap | 20.39T | 167.37B |
Volume | 40.5K | 96.7K |
Lot | 405 | 967 |
Turnover | 869.73M | 23.82M |
Average Price | 21,474.88 | 246.34 |
Value | 869.73M | 23.82M |
Indicative Equilibrium Price | 21,500 | 248 |
Indicative Equilibrium Volume | 200 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metropolitan Kentjana Tbk was established based on notarial deed No. 38 dated March 29, 1972 of Hobropoerwanto, S.H. notary in Jakarta.
Read more on MKPI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →